Archive

July 22, 2025

Browsing

AstraZeneca on Monday announced plans to invest $50 billion in its US operations by 2030, a sweeping commitment that includes building its largest-ever manufacturing facility in Virginia and expanding research and development across several states.

The move comes as global pharmaceutical firms face mounting pressure to relocate production to the United States amid the prospect of steep trade tariffs under the Trump administration.

The Anglo-Swedish biopharmaceutical company said the investment will bolster US manufacturing and research capabilities, with a particular focus on its weight management and metabolic disease portfolio.

A new multi-billion-dollar facility in Virginia will serve as the cornerstone of the initiative and is set to produce, among other products, its oral GLP-1 obesity drug.

“This will be our largest single manufacturing investment globally,” the company said in a statement, noting that the plant will incorporate artificial intelligence, automation and data analytics to improve efficiency.

AstraZeneca’s US expansion

Beyond the Virginia facility, AstraZeneca’s investment will expand cell therapy manufacturing and R&D operations in Maryland, Massachusetts, California, Indiana and Texas.

The company said the initiative would create “tens of thousands of jobs” as it deepens its presence in the world’s largest pharmaceutical market.

CEO Pascal Soriot said the move reflects the company’s confidence in the US as a global leader in life sciences.

“Today’s announcement underpins our belief in America’s innovation in biopharmaceuticals and our commitment to the millions of patients who need our medicines in America and globally,” Soriot said.

AstraZeneca expects half of that projected revenue to come from the US market.

AstraZeneca, which played a major role in the global rollout of COVID-19 vaccines, has steadily increased its US footprint in recent years.

The company reported that the United States accounted for over 40% of its annual revenue in 2024.

In November, it announced a $3.5 billion US investment shortly after the US presidential election.

Earlier this month, The Times reported that AstraZeneca was considering a potential move of its primary listing from London to a US exchange, a shift that analysts described as a blow to the United Kingdom’s public markets.

The company is the most valuable constituent of the FTSE 100 index.

Industry-wide repositioning in response to Trump tariffs

The announcement places AstraZeneca among a growing list of global pharmaceutical companies—including Novartis, Sanofi, Roche, Eli Lilly and Johnson & Johnson—that have pledged to ramp up US investment in recent months.

The moves follow policy signals from US President Donald Trump, who has advocated for reshoring domestic manufacturing and warned the pharmaceutical industry to prepare for aggressive trade measures.

A pending Section 232 investigation into the pharmaceutical sector is expected to conclude by the end of July, with the administration weighing tariffs that could reach as high as 200%.

Trump has proposed a 12- to 18-month grace period to allow pharmaceutical firms to realign their supply chains, though industry leaders have pushed back, citing logistical constraints.

“Typically for most medicines it’s a three to four year horizon,” Novartis CEO Vas Narasimhan said on an earnings call last week.

“We’re working very hard to accelerate that as fast as we can and demonstrate we’re making the investments we have planned,” he added.

As the tariff landscape evolves, AstraZeneca’s announcement signals a broader industry shift to mitigate regulatory risk and secure access to the US market, which remains a key growth driver for the sector.

The post AstraZeneca commits $50B to US expansion amid Trump tariff pressure appeared first on Invezz

The second quarter of 2025 brought more downward pressure for lithium prices, as values for lithium carbonate continued to contract, slipping to their lowest level since January 2021.

After starting the year at US$10,484.37 per metric ton, battery-grade lithium carbonate rose to a year-to-date high of US$10,853.85 on January 27. Prices sank through Q1 and most of Q2, bottoming at US$8,329.08 on June 24.

Lithium hydroxide followed a similar trajectory, with Fastmarkets analysts noting an 89 percent drop in prices for battery-grade lithium hydroxide monohydrate between 2022 and 2025.

“The lithium industry is definitely navigating a period of complexity,” said Paul Lusty, head of battery raw materials at Fastmarkets, at Fastmarkets’ Lithium Supply & Battery Raw Materials conference in June.

“We’re facing headwinds, no doubt, and we’re also seeing quite a lot of negative or bearish sentiment widespread in the market, and I think at times, it’s amplified by voices that really overlooked the phenomenal levels of demand that we’re seeing in many aspects of the market.”

However, Lusty explained that despite facing a multi-quarter price slump, lithium’s long-term drivers remain robust, and are primarily driven by what he described as “mega trends.”

“The fundamentals are really still very strong, and these are anchored in some very powerful, mega trends that we see developing within the global economy; the urgent drive for climate change mitigation, the once in a generational shift in the global energy system, and also the rise of energy intensive technologies such as artificial intelligence,” he said.

Chinese expansions behind lithium oversupply

Although the long-term outlook for lithium remains positive, oversupply and market saturation have added headwinds during the first half of 2025. Demand, particularly from the electric vehicle (EV) sector, remains strong, but global lithium mine supply has outpaced it, rising by an estimated 22 percent in 2024 alone.

“We’re forecasting similar year on year increases for both 2025 and 2026 equivalent to around 260,000 tons of additional (lithium carbonate) alone just this year,” explained Fastmarkets’ Lusty.

“Chinese producers have been particularly aggressive in terms of expanding capacity.” Australia, Argentina and Chile are also driving growth alongside emerging producers like Brazil, and several African nations.

According to data from the US Geological Survey, mined supply from China increased 14.85 percent from 35,700 metric tons in 2023 to 41,000 in 2024, however an asterisk notes that the tallies are estimates, and exact numbers may be “withheld to avoid disclosing company proprietary data.”

For Fastmarkets, the total is likely higher.

“China has rapidly expanded its mining footprint, boosting domestic lithium output by 55 percent since 2023 and is on track to surpass Australia as the world’s top producer by 2026,’ said Lusty. “One of the most notable developments has been the rise of African supply that we started to see over the last two years,” said Lusty.

Africa’s emerging role in the lithium sector

The importance of African supply to the future lithium market was also the topic at Claudia Cook’s presentation, ‘The Lithium Market Shift: China’s and Africa’s Role in Redefining Supply.’

During the 20 minute overview Cook explained that China is increasingly looking to African hard-rock lithium supply to provide feedstock for the country’s growing chemical segment.

So much so that by 2030 18 percent of global hard-rock lithium supply will originate from the continent.

Additionally, the continent will see a 170 percent uptick in hard-rock lithium supply output between 2025 and 2035, according to Cook, who attributes the massive expansion to China’s need to diversify its lithium sources due to domestic supply constraints. To facilitate this demand, China has invested heavily in African production.

“In 2025, 79 percent of African output will be China owned,” she said. “That percentage reduces down to 65 percent in 2035 however, with the increase in tonnage, even though there’s a reduction in percentage, there’ll be an almost doubling in terms of how much that’s actually being put out.”

Regionally, Cook pointed to Zimbabwe and Mali as the country’s poised to see the most growth.

In 2025, Zimbabwe alone is expected to account for 70 percent of African lithium supply, though its share is projected to fall to 43 percent by 2035 as new countries come online.

Despite that shift, African output overall is set to rise significantly, with nations like the DRC, Ethiopia, and Namibia expected to begin production by 2035, said Cook.

Lithium demand surges, but prices lag

The rapid increase in supply has pushed prices to multi year lows, levels that are unsustainable and fail to incentivize new production. Despite this demand remains strong and is expected to grow.

According to the US Geological Survey, global consumption of lithium in 2024 was estimated to be 220,000 tons, a 29 percent increase from revised consumption of 170,000 tons in 2023.

Much of the demand story is attributed to soaring global EV sales, which were up 35 percent in Q1. Lithium consumption in this segment is projected to grow 12 percent annually through 2030.

“Globally, electric car sales this year are forecast to surpass about 20 million units in 2025 representing more than a quarter of all cars sold,” said Lusty.

Future lithium demand remains underpinned by deep structural shifts in global energy consumption.

“We’re witnessing extraordinary battery demand tied to the electrification of the global economy and the rise of renewable energy,” said Lustyt, pointing to surging electricity needs and the increasing role of storage solutions.

In 2024, global electricity demand rose by over 4 percent, adding 1,100 terawatt-hours to the grid, more than Japan’s total annual consumption. This marks the largest year-on-year increase outside post-recession rebounds and reflects broad trends such as greater electricity access, the proliferation of energy-intensive appliances, the expansion of artificial intelligence and data centers, and the shift to electric-powered heavy manufacturing.

Notably, 95 percent of future demand growth is expected to be met by renewables like solar and wind, further boosting the need for battery energy storage systems (BESS) to manage intermittency and stabilize grids.

“Batteries are now essential — not just for EVs, but to balance power systems across sectors,” Lusty added.

Data centers, in particular, are becoming a key growth driver. Since 2017, their electricity use has grown 12 percent annually, according to Fastmarkets, with the US seeing half its centers concentrated in five regional hubs.

By 2030, BESS demand from data centers alone could represent a third of the market, with a projected compound annual growth rate of 35 percent over the next five years.

Overall, lithium demand is forecast to grow 12 percent annually through 2030, underpinned by EV adoption, renewable integration, and digitalization. While China currently accounts for 60 percent of global demand, that dominance is expected to wane as other regions scale up.

“The long-term fundamentals remain intact,” he said, “and it’s hard to envision a future where lithium isn’t central to the global economy.”

What’s next for lithium in 2025?

After June saw prices slip to year-to-date lows, lithium saw a brief uptick in early July amid speculation about supply cuts from Australian miners Mineral Resources (ASX:MN,OTC Pink:MALRF) and Liontown Resources (ASX:LTR,OTC Pink:LINRF). However, gains were reversed after the rumors were denied.

In the US, policy uncertainty continues to weigh on sentiment. A rollback of EV tax credits under the Trump administration could spark a short-term sales bump, but longer-term support appears fragile.

New fair competition rules in China, aimed at curbing downstream dumping, have fueled speculation about broader impacts. While upstream effects are unclear, the policy contributed to July’s brief price rise.

“The nascency of the lithium market means that it is prone to be led by sentiment,” wrote Cook in a monthly update.

‘We have especially seen this at play this month as prices ticked up momentarily mainly from rumors of supply cuts, highlighting how twitchy and reactive the market currently is,’ she continued.

‘These rumors have since been denied … However, with healthy inventory levels and continued ramp-up of production, the reported supply cuts, even if they proved true, may not be enough to dip the market into a deficit.”

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Senate Republican leadership is weighing whether to cancel, or shorten, their upcoming August break following President Donald Trump’s request to stay in town and finish confirming his outstanding nominees. 

Over the last six months, the Senate has moved at a breakneck pace to confirm the president’s nominees all while facing resistance from Senate Democrats. So far, 96 of Trump’s nominees have been confirmed. Still, there are 136 outstanding nominations on the upper chamber’s calendar that haven’t made it over the finish line.

Year in and year out, lawmakers typically escape from the Hill for the entire month of August, either recuperating from months in Washington, D.C., or selling their legislative accomplishments to people back home.

But Trump on Sunday called on Senate Majority Leader John Thune, R-S.D., to keep lawmakers in town to finish their work on confirming his slew of outstanding nominees.

‘Hopefully the very talented John Thune, fresh off our many victories over the past two weeks and, indeed, 6 months, will cancel August recess (and long weekends!), in order to get my incredible nominees confirmed,’ Trump said on his social media platform Truth Social. ‘We need them badly!!! DJT’

Thune said he had spoken with the president about the August recess issue, but did not say whether the entire break would be canceled. A senior GOP aide told Fox News Digital that discussions over shortening the August recess were already happening before Trump’s request.

‘We’re thinking about it,’ Thune said. ‘We want to get as many noms through the pipeline as we can. And honestly, it’d be nice to have Democrats who actually would kind of act more according to historical precedents when it comes to this.’

The remaining spots that need to be filled run across nearly every facet of the federal government, including positions in the Defense Department, Environmental Protection Agency, Commerce Department and a slew of ambassadors, among others.

Among the remaining nominees are some familiar faces from the 2024 election and beyond, including Hung Cao, who ran against Sen. Tim Kaine, D-Va., and was nominated as Navy undersecretary; Donald Trump Jr.’s ex-fiancee Kimberly Guilfoyle, who was tapped to be the U.S. ambassador to Greece, and former Rep. Marc Molinaro, R-N.Y., who was nominated to be Federal Transit administrator.

Thune accused Senate Democrats of being obstructionist and noted that so far, not a single nominee has been approved through the fast-track voice vote or unanimous consent processes. Indeed, every nominee has been put to a floor vote. Only Secretary of State Marco Rubio received a near unanimous, 99 to 0, vote.

Earlier this year, Senate Minority Leader Chuck Schumer, D-N.Y., supported delaying all the president’s nominees who lack unanimous support in the upper chamber, effectively triggering floor votes for each. He also used an arcane Senate procedural move to stall federal prosecutors in committee.

‘This is something that we’re very committed to, and we’re going to be looking at all the options in the next few weeks to try and get as many of those across the finish line as we can,’ Thune said. 

This post appeared first on FOX NEWS